Distinct Transcriptomic Signatures of HIV-1 Tat and gp120 Uncover Differential Neuroimmune Vulnerability in a Gba1-Deficient Synucleinopathy Model
Authors:
- Anna LagniALAnna Lagni
- Virginia LottiVLVirginia Lotti
- Erica DianiErica Diani
- Riccardo CecchettoRCRiccardo Cecchetto
- Stefania TurrinaSTStefania Turrina
- Dario RanieroDRDario Raniero
- Asia PalmisanoAPAsia Palmisano
- Annarita MazzariolAMAnnarita Mazzariol
- Davide GibelliniDGDavide Gibellini
- Giovanna PaoloneGPGiovanna Paolone
Open Access
- 23 July 2026
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (8) , 750
Abstract
HIV-associated neurocognitive disorders (HAND) persist despite effective antiretroviral therapy, indicating that chronic neuroimmune dysfunction extends beyond active viral replication. Among HIV-1-derived factors, the viral proteins Tat and gp120 are contributors to sustained brain inflammation. Nevertheless, their comparative impact in genetically vulnerable neural environments remains unclear. Here, we performed a secondary transcriptomic analysis of publicly available RNA-seq data derived from the striatal tissue of hSNCAA53T Gba1+/L444P mice, a model combining α-synuclein overexpression with Gba1-associated lysosomal impairment, following unilateral intrastriatal injection of Tat or gp120. Both proteins induced robust transcriptional remodelling selectively in the injected striatum. Tat primarily elicited a broad inflammatory amplification programme encompassing innate immune sensing, chemokine recruitment, adaptive immune engagement, and loss of homeostatic support. gp120 preferentially activated antigen presentation, complement, oxidative stress, and lysosomal–phagocytic effector pathways consistent with immune-mediated synaptic stress. Despite these distinct profiles, Tat and gp120 converged on a shared microglia-centred effector core. Contralateral striatal tissue was analyzed as distal non-injected tissue to explore the spatial distribution of transcriptional responses and minimal and protein-specific effects were reported. These findings provide a mechanistic framework for HAND heterogeneity and suggest that HIV protein-driven neuroimmune transcriptional programmes may create a molecular environment compatible with increased neurodegenerative vulnerability in lysosome-compromised, α-synuclein-sensitized brains.Keywords
Funding Information
- Ministry of Universities and Research (2022NXK38S)
This publication has 82 references indexed in Scilit:
- Advances in the Experimental Models of HIV-Associated Neurological DisordersCurrent HIV/AIDS Reports, 2021
- Lysosome and Inflammatory Defects in GBA1‐Mutant Astrocytes Are Normalized by LRRK2 InhibitionMovement Disorders, 2020
- Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and InjuryJournal of Neuroimmune Pharmacology, 2019
- Molecular mechanisms of α-synuclein and GBA1 in Parkinson’s diseaseCell and tissue research, 2017
- Lysosomal Dysfunction and α‐Synuclein Aggregation in Parkinson's Disease: Diagnostic LinksMovement Disorders, 2016
- Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention – A Comparison with Parkinson’s DiseaseNeuropsychology Review, 2015
- Microglia Biology in Health and DiseaseJournal of Neuroimmune Pharmacology, 2006
- HIV‐1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cellsJournal of Neuroscience Research, 2003
- Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, TatJournal of Leukocyte Biology, 1999
- HIV-1 Protein Tat Induces Apoptosis of Hippocampal Neurons by a Mechanism Involving Caspase Activation, Calcium Overload, and Oxidative StressExperimental Neurology, 1998